Literature DB >> 9817878

Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards.

B L Pasloske1, C R Walkerpeach, R D Obermoeller, M Winkler, D B DuBois.   

Abstract

The widespread use of sensitive assays for the detection of viral and cellular RNA sequences has created a need for stable, well-characterized controls and standards. We describe the development of a versatile, novel system for creating RNase-resistant RNA. "Armored RNA" is a complex of MS2 bacteriophage coat protein and RNA produced in Escherichia coli by the induction of an expression plasmid that encodes the coat protein and an RNA standard sequence. The RNA sequences are completely protected from RNase digestion within the bacteriophage-like complexes. As a prototype, a 172-base consensus sequence from a portion of the human immunodeficiency virus type 1 (HIV-1) gag gene was synthesized and cloned into the packaging vector used to produce the bacteriophage-like particles. After production and purification, the resulting HIV-1 Armored RNA particles were shown to be resistant to degradation in human plasma and produced reproducible results in the Amplicor HIV-1 Monitor assay for 180 days when stored at -20 degreesC or for 60 days at 4 degreesC. Additionally, Armored RNA preparations are homogeneous and noninfectious.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817878      PMCID: PMC105245          DOI: 10.1128/JCM.36.12.3590-3594.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

Review 1.  Specific interaction between RNA phage coat proteins and RNA.

Authors:  G W Witherell; J M Gott; O C Uhlenbeck
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1991

2.  Intact ribonucleic acid from defective particles of bacteriophage R17.

Authors:  J E Argetsinger; G N Gussin
Journal:  J Mol Biol       Date:  1966-11-28       Impact factor: 5.469

3.  Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards.

Authors:  B L Pasloske; C R Walkerpeach; R D Obermoeller; M Winkler; D B DuBois
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

4.  A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml.

Authors:  M L Collins; B Irvine; D Tyner; E Fine; C Zayati; C Chang; T Horn; D Ahle; J Detmer; L P Shen; J Kolberg; S Bushnell; M S Urdea; D D Ho
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

5.  In vitro RNA synthesis with SP6 RNA polymerase.

Authors:  P A Krieg; D A Melton
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

Review 6.  Molecular mechanism of RNA phage morphogenesis.

Authors:  P G Stockley; N J Stonehouse; K Valegård
Journal:  Int J Biochem       Date:  1994 Oct-Nov

7.  A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes.

Authors:  B van Gemen; R van Beuningen; A Nabbe; D van Strijp; S Jurriaans; P Lens; T Kievits
Journal:  J Virol Methods       Date:  1994-09       Impact factor: 2.014

8.  Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection.

Authors:  J Mulder; N McKinney; C Christopherson; J Sninsky; L Greenfield; S Kwok
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

9.  Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation.

Authors:  Y Li; H Hui; C J Burgess; R W Price; P M Sharp; B H Hahn; G M Shaw
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Derivation of a biologically contained replication system for human immunodeficiency virus type 1.

Authors:  H Chen; T J Boyle; M H Malim; B R Cullen; H K Lyerly
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

View more
  69 in total

1.  Rapid detection of enterovirus RNA in cerebrospinal fluid specimens with a novel single-tube real-time reverse transcription-PCR assay.

Authors:  W A Verstrepen; S Kuhn; M M Kockx; M E Van De Vyvere; A H Mertens
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

2.  Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus.

Authors:  J D Callahan; S J Wu; A Dion-Schultz; B E Mangold; L F Peruski; D M Watts; K R Porter; G R Murphy; W Suharyono; C C King; C G Hayes; J J Temenak
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  Viability of and plasmid retention in frozen recombinant Escherichia coli over time: a ten-year prospective study.

Authors:  Gina L Koenig
Journal:  Appl Environ Microbiol       Date:  2003-11       Impact factor: 4.792

4.  Applications of competitor RNA in diagnostic reverse transcription-PCR.

Authors:  Steven B Kleiboeker
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

5.  Stable and noncompetitive RNA internal control for routine clinical diagnostic reverse transcription-PCR.

Authors:  Kate E Dingle; Derrick Crook; Katie Jeffery
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

6.  Armored RNA as virus surrogate in a real-time reverse transcriptase PCR assay proficiency panel.

Authors:  S K Hietala; B M Crossley
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

7.  Use of propidium monoazide in reverse transcriptase PCR to distinguish between infectious and noninfectious enteric viruses in water samples.

Authors:  Sandhya Parshionikar; Ian Laseke; G Shay Fout
Journal:  Appl Environ Microbiol       Date:  2010-05-14       Impact factor: 4.792

8.  Rapid genotyping of hepatitis C virus by primer-specific extension analysis.

Authors:  Nick A Antonishyn; Vivian M Ast; Ryan R McDonald; Rabindra K Chaudhary; Lisa Lin; Anton P Andonov; Greg B Horsman
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

9.  Internal control for nucleic acid testing based on the use of purified Bacillus atrophaeus subsp. globigii spores.

Authors:  François J Picard; Martin Gagnon; Marthe R Bernier; Nicholas J Parham; Martine Bastien; Maurice Boissinot; Régis Peytavi; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

10.  Highly sensitive assay for detection of enterovirus in clinical specimens by reverse transcription-PCR with an armored RNA internal control.

Authors:  Marcel Beld; René Minnaar; Jan Weel; Cees Sol; Marjolein Damen; Harry van der Avoort; Pauline Wertheim-van Dillen; Alex van Breda; René Boom
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.